Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

被引：122
|
作者：
Dai, Cong [1 ]
Jiang, Min [1 ]
Sun, Ming-Jun [1 ]
机构：
[1] China Med Univ, Affiliated Hosp 1, Shenyang, Peoples R China
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2017年 / 377卷 / 05期
关键词：
D O I：
10.1056/NEJMc1707500
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 50 条
  • [31] Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
    Sandborn, William J.
    Feagan, Brian G.
    Wolf, Douglas C.
    D'Haens, Geert
    Vermeire, Severine
    Hanauer, Stephen B.
    Ghosh, Subrata
    Smith, Heather
    Cravets, Matthew
    Frohna, Paul A.
    Aranda, Richard
    Gujrathi, Sheila
    Olson, Allan
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (18): : 1754 - 1762
  • [32] Antibiotics for the induction and maintenance of remission in ulcerative colitis
    Gordon, Morris
    Sinopoulou, Vassiliki
    Grafton-Clarke, Ciaran
    Akobeng, Anthony K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (05):
  • [33] Maintenance therapy options for ulcerative colitis
    Chaparro, Maria
    Gisbert, Javier P.
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (10) : 1339 - 1349
  • [34] Vedolizumab for induction and maintenance of remission in ulcerative colitis
    Bickston, Stephen J.
    Behm, Brian W.
    Tsoulis, David J.
    Cheng, Jianfeng
    MacDonald, John K.
    Khanna, Reena
    Feagan, Brian G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
  • [35] Risankizumab for Induction and Maintenance of Remission in Ulcerative Colitis
    Roshanov, Pavel s.
    Khanna, Reena
    GASTROENTEROLOGY, 2025, 168 (03)
  • [36] Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
    Lee, Scott D.
    Allegretti, Jessica R.
    Steinwurz, Flavio
    Connelly, Susan B.
    Lawendy, Nervin
    Paulissen, Jerome
    Gecse, Krisztina B.
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [37] Tofacitinib as a maintenance therapy in patients with ulcerative colitis stratified by OCTAVE Sustain baseline Mayo endoscopic subscore
    Scott D. Lee
    Jessica R. Allegretti
    Flavio Steinwurz
    Susan B. Connelly
    Nervin Lawendy
    Jerome Paulissen
    Krisztina B. Gecse
    BMC Gastroenterology, 23
  • [38] Adalimumab induction and maintenance therapy for patients with ulcerative colitis previously treated with infliximab
    Taxonera, C.
    Estelles, J.
    Fernandez-Blanco, I.
    Merino, O.
    Marin-Jimenez, I.
    Barreiro-de Acosta, M.
    Saro, C.
    Garcia-Sanchez, V.
    Gento, E.
    Bastida, G.
    Gisbert, J. P.
    Vera, I.
    Martinez-Montiel, P.
    Garcia-Moran, S.
    Sanchez, M. C.
    Mendoza, J. L.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (03) : 340 - 348
  • [39] Real-world data of Mirikizumab in the induction and maintenance therapy for ulcerative colitis
    Eleftheriadou, A. M.
    Juhran, K. S.
    Hegazy, A. N.
    Haag, L. M.
    Siegmund, B.
    Sonnenberg, E.
    Charite IBD Grp
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : I1396 - I1396
  • [40] Ozanimod Maintenance Therapy After Cyclosporine Induction in Acute Severe Ulcerative Colitis
    Cohen, Nathaniel A.
    Dalal, Sushila R.
    Choi, David
    Rubin, David T.
    ACG CASE REPORTS JOURNAL, 2022, 9 (07)
12345